Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Breast biopsy & localization · North Carolina | Breast biopsy & localization · Florida | |
|---|---|---|
| Surgeons, 2024 | 133 | 245 |
| Medicare fee-for-service cases | 8,308 | 16,085 |
| Growth since 2019 (Medicare FFS) | −3%/yr | −0.7%/yr |
| Forecast cases (Medicare FFS) | 8,490 in 2030 | 18,600 in 2030 |
| Forecast growth | +0.4%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 9.0 | 7.7 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 45% (−3 pts since 2019) | 39% (−3 pts since 2019) |
| Cases per surgeon | 62 | 66 |
| Top 10 surgeons' share | 22% | 14% |
| Surgeons growing | 19 | 48 |
| New since the base year | 25 | 48 |
| Likely to stop billing it | 21 by 2026 | 38 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,173 | $4,178 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.